Stopping Muscle Scarring in Muscular Dystrophies
Official title: Understanding the Mechanisms of Fibrosis in Muscular Dystrophies
Funded at University of Florida · NIH-11092236 · Data updated 2026-11-12
This project explores how muscle scarring, called fibrosis, develops in muscular dystrophies like Duchenne MD, hoping to find new ways to help muscles heal better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project start | July 12, 2023 |
| Project end | May 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $431,052 |
| NIH project number | 5R01AR083108-03 |
| Project ID | NIH-11092236 on NIH RePORTER |
Who could benefit from this research
✓Could help
This foundational research is relevant to patients with muscular dystrophies, particularly those with Duchenne MD, as it seeks to understand the underlying disease processes.
✕Less likely to help
Patients without muscular dystrophies or related muscle wasting conditions would not directly benefit from this specific research.
What this research studies
Muscular dystrophies cause muscles to weaken and waste away, eventually being replaced by scar tissue and fat. This scarring prevents muscles from regenerating properly, which is a major challenge for patients. Our team is looking into specific cell processes that contribute to this scarring and prevent muscle repair. We are focusing on a particular target, NOX4, which has shown promise in reducing muscle scarring and improving muscle health in models of Duchenne MD. We believe NOX4 in certain cells might be preventing the body from clearing away scar-forming cells after muscle injury.
Why it matters
Potential benefit: If successful, this work could lead to new treatments that reduce muscle scarring and improve muscle regeneration for individuals living with muscular dystrophies.
How similar studies have gone: Previous work has shown that targeting NOX4 using genetic and pharmacological methods led to significant reductions in muscle fibrosis and improved muscle remodeling in severely dystrophic muscle models.
Where this research is happening
-
University of Florida
Gainesville, United States Active
Researchers
- Principal investigator: Hammers, David W — University of Florida
- Study coordinator: Hammers, David W
Related research
Other NIH-funded projects on the same topics.
-
Understanding why scarring happens in muscular dystrophy muscles
Researchers are studying why scar tissue forms in muscles affected by muscular dystrophy and how to slow or reverse it in patients.
-
Interface between immune cells and scarring in the eye
This grant looks at how immune cells influence scar formation in the cornea after injury and how this affects vision.
-
How often to treat schistosomiasis to protect the liver
A randomized trial will test different frequencies ofPraziquantel treatment to prevent liver damage in people aged 15–40 with schistosomiasis in Uganda.
-
Metabolic changes in cells that repair blood vessels in the eye lens to prevent scarring
A drug or approach that changes how certain cells that repair blood vessels in the eye work, to prevent scarring behind the retina in age-related macular degeneration patients treated with anti-VEGF therapy.
-
Myocardial fibrosis and fat in ART-treated women with HIV in sub-Saharan Africa
This project studies heart tissue changes in women with HIV in sub-Saharan Africa who are on antiretroviral therapy, to understand why they’re at higher risk for heart problems as they age.
-
Myocardial fibrosis and fat in ART-treated women with HIV in sub-Saharan Africa
This grant studies heart tissue changes in women living with HIV in sub-Saharan Africa to understand why heart failure risk is higher in this group.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.